We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Immune Pharma Announces Exclusive License

News   Jan 04, 2016

 
Immune Pharma Announces Exclusive License
 
 
 

RELATED ARTICLES

Scientists Produce a Potential Vitamin and Alzheimer’s Drug in Yeast

News

By engineering and optimizing baker's yeast, scientists from The Novo Nordisk Foundation Center for Biosustainability (DTU Biosustain) has for the first time exploited the potential of making ergothioneine in yeast in a bio-based fashion.

READ MORE

Anti-inflammatory Drug May Raise Diabetes Risk

News

A commonly prescribed anti-inflammatory drug may increase diabetes risk after just one week of treatment, according to new findings presented at The Society for Endocrinology Annual Conference.

READ MORE

A Tailored Cancer Therapy Based on HLA Gene Profile?

News

Researchers have discovered that patients with a wide variety of HLA molecules may derive more benefit from a specific type of cancer therapy.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE